Composition for preventing, alleviating, or treating allergic skin disease comprising as active ingredient extract of gardenia fruit from which pigment is removed

US12186356B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12186356-B2
Application numberUS-201917258253-A
CountryUS
Kind codeB2
Filing dateJul 10, 2019
Priority dateJul 10, 2018
Publication dateJan 7, 2025
Grant dateJan 7, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a composition for preventing, alleviating, or treating allergic skin diseases comprising, as an active ingredient, an extract of gardenia fruit from which pigment is removed, and since the extract of gardenia fruit from which pigment is removed is more effective for allergic skin diseases compared to an extract of gardenia fruit from which pigment is not removed, the composition can be very advantageously used for allergic skin diseases, in particular, atopic dermatitis.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for treating an allergic disease, the method comprising administering to a subject in need thereof a composition comprising, as an active ingredient, an extract of gardenia fruit from which pigment is removed, wherein the pigment is crocin. 2. The method of claim 1 , wherein the allergic disease is selected from the group consisting of atopic dermatitis, allergic dermatitis, contact dermatitis, skin hives, itch, insect allergy, food allergy, drug allergy, edema, anaphylaxis, allergic rhinitis, asthma, allergic conjunctivitis, and a combination thereof. 3. The method of claim 1 , wherein the extract of gardenia fruit from which pigment is removed is produced by: carrying out first extraction by adding an extraction solvent to gardenia fruit followed by filtration to obtain a first filtrate; adding an extraction solvent to residues remained after obtaining the first filtrate to obtain a second filtrate; mixing the first filtrate with the second filtrate; adding activated carbon for allowing pigment of gardenia fruit extract to get adsorbed onto the activated carbon; removing the activated carbon; and obtaining the extract of gardenia fruit from which the pigment is removed by filtration, concentration, and drying. 4. The method of claim 1 , wherein the composition is a pharmaceutical composition. 5. The method of claim 1 , wherein the composition is included in a quasi-pharmaceutical product. 6. The method of claim 5 , wherein the quasi-pharmaceutical product is a skin preparation for external use. 7. The method of claim 1 , wherein the composition is a functional health food composition.

Assignees

Inventors

Classifications

  • Pre-filtration · CPC title

  • Applications, solvents · CPC title

  • Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization · CPC title

  • Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying · CPC title

  • Complex extraction schemes, e.g. fractionation or repeated extraction steps · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12186356B2 cover?
The present invention relates to a composition for preventing, alleviating, or treating allergic skin diseases comprising, as an active ingredient, an extract of gardenia fruit from which pigment is removed, and since the extract of gardenia fruit from which pigment is removed is more effective for allergic skin diseases compared to an extract of gardenia fruit from which pigment is not removed…
Who is the assignee on this patent?
Korea Inst Oriental Medicine
What technology area does this patent fall under?
Primary CPC classification A61K36/744. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).